Bayer

Page 2 of 6

Bill Anderson, chief executive officer of Bayer AG
Finance

Bayer had its worst day ever as shares sunk to the lowest in over a decade on $1.5bn Roundup verdict and drug failure

By Tim Loh and Bloomberg
November 20, 2023
Roundup
Health

57-year-old man wins $332 million verdict against Monsanto on claim that Roundup weedkiller gave him incurable cancer

By
November 3, 2023
Bayer hit with $332 million judgement in trial of man who blames his cancer on decades using Monsanto’s Roundup weedkiller
Finance

Bayer hit with $332 million judgement in trial of man who blames his cancer on decades using Monsanto’s Roundup weedkiller

By
November 3, 2023
Sudafed
Health

The top decongestant on the market doesn’t actually decongest, FDA says

By Matthew Perrone and The Associated Press
September 12, 2023
Shareholders are forcing Bayer’s CEO out. What do they expect from his replacement?
Newsletters

Shareholders are forcing Bayer’s CEO out. What do they expect from his replacement?

By
March 10, 2023
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
Finance

The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021

By
August 15, 2022
The ‘everything rally’ continues: Bitcoin, ether at all-time highs while stocks go for 9-straight
Newsletters

The ‘everything rally’ continues: Bitcoin, ether at all-time highs while stocks go for 9-straight

By
November 9, 2021
In this photo illustration the Covax Facility logo seen displayed on a smartphone screen with the logo of CureVac in the background.
Health

CureVac scraps its first-generation COVID-19 vaccine candidate, shares tumble

By
October 12, 2021
An employee checks bottles of diluent inside the pharmaceutical plant Fareva in Poce-sur-Cisse, Central France, on April 22, 2021. Fareva was chosen as the main supplier of the candidate RNA messenger vaccine from the German company CureVac. The site will therefore produce the diluent used in this vaccine.
Health

These four COVID-19 vaccines could soon join the pandemic fight

By
May 8, 2021
An illustrative image of medical syringes in front of CureVac and Bayer logos displayed on a screen.
Health

As alarm grows over Europe’s dwindling vaccine supplies, Bayer could offer its factories to the cause

By
January 18, 2021
The logo of the biopharmaceutical company CureVac, is displayed in front of the company's headquarters in Tuebingen, southern Germany on December 15, 2020.
Health

Bayer strikes deal to aid CureVac in its COVID-19 vaccine rollout

By
January 7, 2021
The dollar, Bitcoin soar as the markets contend with a dreaded, contested election
Newsletters

The dollar, Bitcoin soar as the markets contend with a dreaded, contested election

By
November 4, 2020
Roundup weed killer that is the subject of thousands of lawsuits in the US, is pictured on sale in Los Angeles, California on September 1, 2019.
International

Bayer could settle the Roundup cancer litigation, but the drama is far from over

By
June 25, 2020
Bayer agrees to pay $12 billion in legal settlements, in effort to put Roundup scandal behind it
International

Bayer agrees to pay $12 billion in legal settlements, in effort to put Roundup scandal behind it

By Jef Feeley, Tim Loh and Bloomberg
June 25, 2020
From beekeepers to giant pension funds, activist shareholders are being silenced by the coronavirus
Finance

From beekeepers to giant pension funds, activist shareholders are being silenced by the coronavirus

By Bernhard Warner and Katherine Dunn
June 6, 2020

Most Popular